RESÚMENES ABRIL 2009

.

Child & Adolescent Disorders

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3! - Treated depression in adolescents: predictors of outcome at 28 weeks

Paul Wilkinson, Bernadka Dubicka, Raphael Kelvin, Chris Roberts, Ian Goodyer

The British Journal of Psychiatry (2009) 194: 334-341

 

3! - Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study

David A. Brent, Graham J. Emslie, Greg N. Clarke, Joan Asarnow, Anthony Spirito, Louise Ritz, Benedetto Vitiello, Satish Iyengar, Boris Birmaher, Neal D. Ryan, Jamie Zelazny, Matthew Onorato, Betsy Kennard, Taryn L. Mayes, Lynn L. DeBar, James T. McCracken, Michael Strober, Robert Suddath, Henrietta Leonard, Giovanna Porta, and Martin B. Keller

Am J Psychiatry 2009; 166:418-426

3 - Lisdexamfetamine for Treatment of Attention-Deficit/Hyperactivity Disorder

Brian J Cowles

The Annals of Pharmacotherapy: Vol. 43, No. 4, pp. 669-676

 

3 - Childhood Predictors of Completed and Severe Suicide Attempts. Findings From the Finnish 1981 Birth Cohort Study

Andre Sourander, Anat Brunstein Klomek, Solja Niemelä, Antti Haavisto, David Gyllenberg, Hans Helenius, Lauri Sillanmäki, Terja Ristkari, Kirsti Kumpulainen, Tuula Tamminen, Irma Moilanen, Jorma Piha, Fredrik Almqvist, Madelyn S. Gould

Arch Gen Psychiatry. 2009;66(4):398-406

 

5< - Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jack R. Cornelius, Oscar G. Bukstein, D. Scott Wood, Levent Kirisci, Antoine Douaihy and Duncan B. Clark

Addictive Behaviors. April 2009; Article in Press

 

3 - The Behavioral Spectrum of Gilles de la Tourette Syndrome

Andrea Eugenio Cavanna, Serena Servo, Francesco Monaco, and Mary May Robertson

J Neuropsychiatry Clin Neurosci 21:13-23

 

3! - Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents

Chadi A. Calarge, Laura Acion, Samuel Kuperman, Michael Tansey, Janet A. Schlechte

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 101-109

 

3 - Retrial of Selective Serotonin Reuptake Inhibitors in Children with Pervasive Developmental Disorders: A Retrospective Chart Review

Charles A. Henry, David Shervin, Ann Neumeyer, Ronald Steingard, Jessaca Spybrook, Roula Choueiri, Margaret Bauman

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 111-117

 

4 - Activation Adverse Events Induced by the Selective Serotonin Reuptake Inhibitor Fluvoxamine in Children and Adolescents

Shauna P. Reinblatt, Susan dosReis, John T. Walkup, Mark A. Riddle

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 119-126

 

5 - Dopamine-Related Genotypes and the Dose–Response Effect of Methylphenidate on Eating in Attention-Deficit/Hyperactivity Disorder Youths

John J. Leddy, James G. Waxmonsky, Robert J. Salis, Rocco A. Paluch, Elizabeth M. Gnagy, Patrick Mahaney, Richard Erbe, William E. Pelham, Leonard H. Epstein

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 127-136

 

3! - The Open-Label Treatment of Attention-Deficit/Hyperactivity Disorder in 4- and 5-Year-Old Children with Beaded Methylphenidate

Lawrence Maayan, Natalya Paykina, Jane Fried, Tara Strauss, S. Sonia Gugga, Laurence Greenhill

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 147-153

 

3! - Prospective, Naturalistic, Pilot Study of Open-Label Atomoxetine Treatment in Preschool Children with Attention-Deficit/Hyperactivity Disorder

Jaswinder K. Ghuman, Michael G. Aman, Harinder S. Ghuman, Thomas Reichenbacher, Alan Gelenberg, Ron Wright, Sydney Rice, Carolyn Fort

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 155-166

 

5 - The Influence of Short-Chain Essential Fatty Acids on Children with Attention-Deficit/Hyperactivity Disorder: A Double-Blind Placebo-Controlled Study

Raanan Raz, Rafael L. Carasso, Shlomo Yehuda

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 167-177

 

3! - Determinants of Initial Pharmacological Treatment for Youths with Attention-Deficit/Hyperactivity Disorder

Chih-Ying Chen, Tobias Gerhard, Almut G. Winterstein

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 187-195

 

3 - Effectiveness of Mirtazapine in the Treatment of Inappropriate Sexual Behaviors in Individuals with Autistic Disorder

Murat Coskun, Sevcan Karakoc, Fuat Kircelli, Nahit Motavalli Mukaddes

Journal of Child and Adolescent Psychopharmacology. 2009, 19(2): 203-206

 

3 - The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Doug Hyun Han, Young Sik Lee, Churl Na, Jee Young Ahn, Un Sun Chung, Melissa A. Daniels, Charlotte A. Haws and Perry F. Renshaw

Comprehensive Psychiatry. Volume 50, Issue 3, May-June 2009, Pages 251-256

 

3 - Infants of Depressed Mothers

Edward Tronick; Corrina Reck

Harvard Review of Psychiatry, Volume 17, Issue 2 April 2009, pages 147 - 156

 

3 - Poor response inhibition: At the nexus between substance abuse and attention deficit/hyperactivity disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Stephanie M. Groman, Alex S. James and J. David Jentsch

Neuroscience & Biobehavioral Reviews. Volume 33, Issue 5, May 2009, Pages 690-698

3 - Hyperserotonemia in autism: activity of 5HT-associated platelet proteins

Biological Psychiatry - Original Article

Hyperserotonemia in autism: activity of 5HT-associated platelet proteins

Dubravka Hranilović, Zorana Bujas-Petković, Maja Tomičić, Tatjana Bordukalo-Nikšić, Sofia Blažević and Lipa Čičin-Šain

Journal of Neural Transmission. Volume 116, Number 4 / April, 2009: 493-501

 

3 - ADHD Subtypes and Co-Occurring Anxiety, Depression, and Oppositional-Defiant Disorder. Differences in Gordon Diagnostic System and Wechsler Working Memory and Processing Speed Index Scores

Susan Dickerson Mayes, Susan L. Calhoun, Gary A. Chase, Danielle M. Mink, Ryan E. Stagg

Journal of Attention Disorders, Vol. 12, No. 6, 540-550 (2009)

3! - Combined Cognitive-Behavioural Therapy and Pharmacotherapy for Adolescent Depression: Does it Improve Outcomes Compared with Monotherapy?

Vitiello, Benedetto

CNS Drugs. 23(4):271-280, 2009

3! - Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters?

Biological Child and Adolescent Psychiatry - Original Article

Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters?

Sheila P. Garcia, Julia Guimarães, Juliana F. Zampieri, Ana Luiza Martinez, Guilherme Polanczyk and Luis Augusto Rohde

Journal of Neural Transmission. On Line First. April 2009

 

3! - Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)




References and further reading may be available for this article. To view references and further reading you must purchase this article.

V. Emond, C. Joyal and H. Poissant

L'Encéphale. Volume 35, Issue 2, April 2009, Pages 107-114

 

GRATIS 3! - Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force

Selvi B. Williams, Elizabeth A. O’Connor, Michelle Eder, Evelyn P. Whitlock

Pediatrics 2009;123:e716–e735

 

3 - Timing of Identification Among Children With an Autism Spectrum Disorder: Findings From a Population-Based Surveillance Study

SHATTUCK, PAUL T; DURKIN, MAUREEN; MAENNER, MATTHEW; NEWSCHAFFER, CRAIG; MANDELL, DAVID S; WIGGINS, LISA; LEE, LI-CHING; RICE, CATHERINE; GIARELLI, ELLEN; KIRBY, RUSSELL; BAIO, JON; PINTO-MARTIN, JENNIFER; CUNIFF, CHRISTOPHER

Journal of the American Academy of Child & Adolescent Psychiatry: May 2009 - Volume 48 - Issue 5 - pp 474-483

 

3! - The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

MOLINA, BROOKE; HINSHAW, STEPHEN P; SWANSON, JAMES M; ARNOLD, L. EUGENE; VITIELLO, BENEDETTO; JENSEN, PETER S; EPSTEIN, JEFFERY N; HOZA, BETSY; HECHTMAN, LILY; ABIKOFF, HOWARD B; ELLIOTT, GLEN R; GREENHILL, LAURENCE L; NEWCORN, JEFFREY H; WELLS, KAREN C; WIGAL, TIMOTHY; GIBBONS, ROBERT D; HUR, KWAN; HOUCK, PATRICIA R; the MTA Cooperative Group

Journal of the American Academy of Child & Adolescent Psychiatry: May 2009 - Volume 48 - Issue 5 - pp 484-500

 

3! - Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment

PAPPADOPULOS, ELIZABETH; JENSEN, PETER S; CHAIT, ALANNA R; ARNOLD, L. EUGENE; SWANSON, JAMES M; GREENHILL, LAURENCE L; HECHTMAN, LILY; CHUANG, SHIRLEY; WELLS, KAREN C; PELHAM, WILLIAM; COOPER, THOMAS; ELLIOTT, GLENN; NEWCORN, JEFFREY H

Journal of the American Academy of Child & Adolescent Psychiatry: May 2009 - Volume 48 - Issue 5 - pp 501-510

 

4 - Clinical Responses to Atomoxetine in Attention-Deficit/Hyperactivity Disorder: The Integrated Data Exploratory Analysis (IDEA) Study

NEWCORN, JEFFREY H; SUTTON, VIRGINIA K; WEISS, MARGARET D; SUMNER, CALVIN R

Journal of the American Academy of Child & Adolescent Psychiatry: May 2009 - Volume 48 - Issue 5 - pp 511-518

 

5< - A Double-Blind, Randomized, Placebo-Controlled Trial of Divalproex Extended-Release in the Treatment of Bipolar Disorder in Children and Adolescents

WAGNER, KAREN DINEEN; REDDEN, LAURA; KOWATCH, ROBERT A; WILENS, TIMOTHY E; SEGAL, SCOTT; CHANG, KIKI; WOZNIAK, PATRICIA; VIGNA, NAMITA V; ABI-SAAB, WALID; SALTARELLI, MARIO

Journal of the American Academy of Child & Adolescent Psychiatry: May 2009 - Volume 48 - Issue 5 - pp 519-532

 

3 - Paediatric obsessive–compulsive disorder, a neurodevelopmental disorder?: Evidence from neuroimaging




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Chaim Huyser, Dick J. Veltman, Else de Haan and Frits Boer

Neuroscience & Biobehavioral Reviews. Volume 33, Issue 6, June 2009, Pages 818-830

 

3! - Aripiprazole in Children and Adolescents With Bipolar Disorder Comorbid With Attention-Deficit/Hyperactivity Disorder: A Pilot Randomized Clinical Trial

Silzá Tramontina, Cristian P. Zeni, Carla R. Ketzer, Gabriel F. Pheula, Joana Narvaez, and Luis Augusto Rohde

J Clin Psychiatry April 21, 2009: e1-e9

 

3! - Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Paul Hammerness, Timothy Wilens, Eric Mick, Thomas Spencer, Robert Doyle, Michelle McCreary, Judith Becker and Joseph Biederman

The Journal of Pediatrics. Article in Press, April 2009

 

GRATIS (previo registro) 3 - Eficacia sostenida del metilfenidato de liberación osmótica: estudio en 266 casos

A. Fernández-Jaén, D. Martín Fernández-Mayoralas, B. Calleja-Pérez, N. Muñoz-Jareño

REV NEUROL 2009;48:339-345

.

Regresar a RESÚMENES ABRIL 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.